Neonatal Abstinence Syndrome and Associated Health Care Expenditures

作者: Stephen W. Patrick , Robert E. Schumacher , Brian D. Benneyworth , Elizabeth E. Krans , Jennifer M. McAllister

DOI: 10.1001/JAMA.2012.3951

关键词:

摘要: Context Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal primarily caused by maternal opiate use. No national estimates are available for the incidence of use at time delivery or NAS. Objectives To determine NAS and antepartum to characterize trends in health care expenditures associated with between 2000 2009. Design, Setting, Patients A retrospective, serial, cross-sectional analysis nationally representative sample newborns The Kids' Inpatient Database (KID) was used identify International Classification Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code. Nationwide Sample (NIS) mothers using diagnosis related groups vaginal cesarean deliveries. conditions were identified ICD-9-CM codes. described as an annual frequency per 1000 hospital births. Missing charges ( Main Outcome Measures Incidence use, charges. Results separate years (2000, 2003, 2006, 2009) discharge data included 2920 9674 unweighted discharges 987 4563 diagnosed within sets including 784 191 1.1 million children 816 554 879 910 all ages delivering (NIS). Between 2009, among increased from 1.20 (95% CI, 1.04-1.37) 3.39 3.12-3.67) births year (P trend  Conclusion substantial increase United States observed, well

参考文章(36)
Karol Kaltenbach, Vincenzo Berghella, Loretta Finnegan, OPIOID DEPENDENCE DURING PREGNANCY Obstetrics and Gynecology Clinics of North America. ,vol. 25, pp. 139- 151 ,(1998) , 10.1016/S0889-8545(05)70362-4
John D. Madden, John N. Chappel, Frederick Zuspan, Janis Gumpel, Alfonso Mejia, Roy Davis, Observation and treatment of neonatal narcotic withdrawal American Journal of Obstetrics and Gynecology. ,vol. 127, pp. 199- 201 ,(1977) , 10.1016/S0002-9378(16)33250-1
Leonard J. Paulozzi, Rose A. Rudd, Karin A. Mack, Christopher M. Jones, Vital Signs: Overdoses of Prescription Opioid Pain Relievers - United States, 1999-2008 Morbidity and Mortality Weekly. ,vol. 60, pp. 1487- ,(2011)
David A Osborn, Heather E Jeffery, Michael J Cole, Sedatives for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews. ,vol. 5, ,(2010) , 10.1002/14651858.CD002053.PUB3
Silvia Minozzi, Laura Amato, Shayesteh Jahanfar, Cristina Bellisario, Marica Ferri, Marina Davoli, Maintenance agonist treatments for opiate dependent pregnant women Cochrane Database of Systematic Reviews. ,vol. 11, ,(2013) , 10.1002/14651858.CD006318.PUB3
Stephen R. Kandall, Lawrence M. Gartner, Arthur I. Eidelman, Susan Albin, Joyce Lowinson, Beatrice Berle, Differential effects of maternal heroin and methadone use on birthweight Pediatrics. ,vol. 58, pp. 681- 685 ,(1976)
C Dryden, D Young, M Hepburn, H Mactier, Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. British Journal of Obstetrics and Gynaecology. ,vol. 116, pp. 665- 671 ,(2009) , 10.1111/J.1471-0528.2008.02073.X
Mara G. Coyle, Anne Ferguson, Linda Lagasse, William Oh, Barry Lester, Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants The Journal of Pediatrics. ,vol. 140, pp. 561- 564 ,(2002) , 10.1067/MPD.2002.123099
Hendrée E. Jones, Kevin E. O'Grady, Debbie Malfi, Michelle Tuten, Methadone maintenance vs. methadone taper during pregnancy: Maternal and neonatal outcomes American Journal on Addictions. ,vol. 17, pp. 372- 386 ,(2008) , 10.1080/10550490802266276